Inhibition of Lnc-THOR-IGF2BP1 cascade will induce MAGEA6 downregulation, AMPKα1 expression, and AMPK signaling activation, inhibiting glioma cell survival in vitro and in vivo. Here, THORLNC is linked to central nervous system cancer.